1. Home
  2. XMTR vs STVN Comparison

XMTR vs STVN Comparison

Compare XMTR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xometry Inc.

XMTR

Xometry Inc.

HOLD

Current Price

$94.31

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.84

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
XMTR
STVN
Founded
2013
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
XMTR
STVN
Price
$94.31
$17.84
Analyst Decision
Buy
Buy
Analyst Count
10
3
Target Price
$58.60
$25.67
AVG Volume (30 Days)
774.4K
364.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
26.95
N/A
EPS
N/A
N/A
Revenue
$686,631,000.00
N/A
Revenue This Year
$23.76
$9.67
Revenue Next Year
$18.38
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
25.87
N/A
52 Week Low
$30.63
$12.89
52 Week High
$99.86
$28.00

Technical Indicators

Market Signals
Indicator
XMTR
STVN
Relative Strength Index (RSI) 66.64 50.76
Support Level $56.76 $16.75
Resistance Level $99.86 $19.41
Average True Range (ATR) 4.44 0.96
MACD -0.13 -0.01
Stochastic Oscillator 96.41 51.78

Price Performance

Historical Comparison
XMTR
STVN

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: